We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Single Domain Antibodies: From Conformational Sensors to Bispecific Antibodies for Immunotherapy

Video   Dec 23, 2016

 

Single domain antibodies (AKA nanobodies), the variable domains of some camelid antibodies, have interesting properties, including high production yields and stability but also the ability to bind unusual epitopes such as cleft and cavities. We are using them as innovative tools such as biosensors able to capture the conformation states of some membrane receptors such as EGFR or metabotropic glutamate receptors (mGluRs) on living cells. Combined with time-resolved FRET assays, they can reveal the fine mechanisms of receptor activation at the cell surface.Single domain antibodies also represent efficient building blocks to create bispecific molecules that we are using to immunomolulate effectors cells in the tumor microenvironment. An example will be given with the activation of effector cells such as NK cells in the context of tumor cells expressing low amount of tumor antigens, outperforming the classical ADCC mechanisms.

 
 
 
Advertisement
 

Recommended Videos

SARS-CoV-2 Infected Host Cell Proteomics Reveal Potential Therapy Targets

Video

As part of the London Proteomics Discussion Group webinar series: "SARS-CoV-2: What role can proteomics play?" Dr Münch presented his work on changes in response to SARS-CoV-2 infection, highlighting potential therapies.

WATCH NOW

Unlocking the Protein Structure of Coronavirus

Video

The novel coronavirus sweeping the globe packs 27 proteins, each adopting a unique, often incredibly complex 3D structure. Each protein is part of the molecular toolkit that the virus uses to infect, replicate, and spread. Understanding the proteins' structures provides a blueprint for drug designs.

WATCH NOW

Testimonial: Use of Rotavapors for Drug Discovery and Formulation in Academic Research

Video

Dr. Fabiana Quaglia, Associate Professor of Pharmaceutical Technology at the Faculty of Pharmacy–University of Napoli Federico II, Italy discusses how reliability and smart features of the rotary evaporator, Rotavapor® R-300, let her easily evaporate solvents in particle production for cancer and cystic fibrosis drug development and formulation.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE